• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    HUTCHMED Highlights Sovleplenib, Hematology Data At Upcoming EHA 2024

    GLOBENEWSWIRE

    Hutchmed Announces NDA Acceptance in China for Sovleplenib

    GLOBENEWSWIRE

    Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

    ONCLIVE

    HUTCHMED Announces that Sovleplenib PIII ESLIM-01 Study Met Its Primary Endpoint

    GLOBENEWSWIRE

    HUTCHMED Completes Patient Enrollment of ESLIM-01, a Ph III Trial of Sovleplenib

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.